scorecardresearch
Wednesday, May 28, 2025
TopicNovartis

Topic: Novartis

In Delhi hospitals, thalassemia patients suffer as life-saving Desferal scarce, set to become 50% costlier

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no shortage in supply.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

It’ll take more than vaccines to fight Covid, Novartis CEO Narasimhan says

Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.

On Camera

Trump’s corruption is eroding America’s global power. India can’t count on it

The goals India cares about—containing China, targeting jihadists in Pakistan, securing trade routes and energy—don’t seem to matter to Trump.

No competition, have to deliver faster & reliably, says Amazon India V-P of operations

Diving into workings of Gurugram fulfilment centre, Abhinav Singh, V-P (Ops) at Amazon India, offers insights into how company manages logistics, in conversation with ThePrint Editor-in-Chief Shekhar Gupta.

3 oceans & a crew of 2 on historic voyage: Women Navy officers to return home after 8 months at sea

Lieutenant Commanders Dilna K & Roopa A’s expedition aboard INSV Tarini is the first-ever such global circumnavigation by Indian women in a double-handed mode.

There’s an all-new N-word now. And India’s soft power has become its hard liability

India is better positioned in the world than at any point post-Cold war. We have to decide if global opinion matters to us or not. If it does, we must engage with their media, think tanks, civil society.